SCHEMBL7871201

SCHEMBL7871201

Clc1cccc(COCC2CCN(C[C@H]3CN(Cc4ccc(Cl)cc4Cl)C[C@@H]3c3ccsc3)CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 6/20 0.47
SIGMAR1 Q99720 1/20 0.37
MCHR1 Q99705 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
BACE1 P56817 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
CXCR4 P61073 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7871198 1.00 CCR5 (0.47) CCR5SIGMAR1MCHR1BCHEACHE
SCHEMBL7863096 0.94 CCR5 (0.48) CCR5SIGMAR1BCHEACHEBACE1
SCHEMBL7863308 0.93 CCR5 (0.42) CCR5KDM4E
SCHEMBL7863310 0.93 CCR5 (0.42) CCR5KDM4E
SCHEMBL7863248 0.92 CCR5 (0.40) CCR5MCHR1KDM4E
SCHEMBL7863247 0.92 CCR5 (0.40) CCR5MCHR1KDM4E
SCHEMBL7868450 0.92 CCR5 (0.42) CCR5SIGMAR1KDM4EALDH1A1MEN1
SCHEMBL7868448 0.92 CCR5 (0.42) CCR5SIGMAR1KDM4EALDH1A1MEN1
SCHEMBL7521940 0.90 CCR5 (0.43) CCR5SIGMAR1KDM4EALDH1A1MEN1
SCHEMBL7521934 0.90 CCR5 (0.43) CCR5SIGMAR1KDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US claimed
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed
WO-2000051608-A1 3-THIENYL AND 3-FURANYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed